FDA Drug Recalls

Recalls / Class II

Class IID-0655-2022

Product

0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDC 0264-7800-20

Brand name
Sodium Chloride
Generic name
Sodium Chloride
Active ingredient
Sodium Chloride
Route
Intravenous
NDCs
0264-7800, 0264-7802
FDA application
NDA019635
Affected lot / code info
Lot #: J1E086, J1E204, J1E213, Exp 5/31/2023; J1H137, J1H138, Exp 6/30/2023

Why it was recalled

Lack of sterility assurance: leaking bags

Recalling firm

Firm
B. Braun Medical, Inc.
Manufacturer
B. Braun Medical Inc.
Notification channel
Other
Type
Voluntary: Firm initiated
Address
901 Marcon Blvd, N/A, Allentown, Pennsylvania 18109-9512

Distribution

Quantity
33,742 bags
Distribution pattern
USA Nationwide

Timeline

Recall initiated
2022-02-25
FDA classified
2022-03-17
Posted by FDA
2022-03-23
Terminated
2023-03-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0655-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Sodium Chloride · FDA Drug Recalls